Francis C. Hsiao

Cutting Edge: Epstein-Barr Virus Transactivates the HERV-K18 Superantigen by Docking to the Human Complement Receptor 2 (CD21) on Primary B Cells1

Gang Chen, B. Huber, A. Tai, 2006, The Journal of Immunology.

Refractory cutaneous angiosarcoma successfully treated with sunitinib

C. Tzeng, T. Chao, H. Lu, 2013, The British journal of dermatology.

Murine Vβ3+ and Vβ7+ T Cell Subsets Are Specific Targets for the HERV-K18 Env Superantigen1

Gang Chen, B. Huber, A. Tai, 2006, The Journal of Immunology.

Murine V 3 and V 7 T Cell Subsets Are Specific Targets for the HERVK HERVK HERVK 18 Env Superantigen 1

Gang Chen, B. Huber, A. Tai, 2006 .

Superantigen Specific Targets for the HERV-K 18 Env T Cell Subsets Are + 7 β and V + 3 β Murine V

B. Huber, A. Tai, N. Sutkowski, 2006 .

15. Skin Flaps

H. Gladstone, K. Nouri, T. H. Nguyen, 2012 .

Recent Advances in Fractional Laser Resurfacing: New Paradigm in Optimal Parameters and Post-Treatment Wound Care.

D. Eisen, Francis C. Hsiao, G. Bock, 2012, Advances in wound care.

EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM.

R. Longnecker, B. Huber, A. Tai, 2009, Virology.

Murine Vbeta3+ and Vbeta7+ T cell subsets are specific targets for the HERV-K18 Env superantigen.

Gang Chen, B. Huber, A. Tai, 2006, Journal of immunology.

Refractory cutaneous angiosarcoma successfully treated with sunitinib

C. Tzeng, Francis C. Hsiao, C. Shiau, 2013, The British journal of dermatology.

Botulinum Toxin Type A for Relief of Intractable Pain After Face and Brow-Lift Surgery.

Andrea Willey, Francis C. Hsiao, M. McClaren, 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].